Vaginal epithelial cell anti-Candida albicans activity is associated with protection against symptomatic vaginal candidiasis
Barousse, M.M.; Espinosa, T.; Dunlap, K.; Fidel, P.L.
Infection and Immunity 73(11): 7765-7767
2005
ISSN/ISBN: 0019-9567
PMID: 16239581
DOI: 10.1128/iai.73.11.7765-7767.2005
Accession: 013218958
Vaginal epithelial cell (VEC) anti-Candida albicans activity, despite being measured in vitro, is considered an innate host defense mechanism. This was supported further by the fact that women protected from symptomatic infection following a live intravaginal Candida challenge had increased VEC anti-Candida activity compared to those who acquired a symptomatic infection.
PDF emailed within 0-6 h: $19.90
Related References
Yano, J.; Palmer, G.E.; Eberle, K.E.; Peters, B.M.; Vogl, T.; McKenzie, A.N.; Fidel, P.L. 2014: Vaginal epithelial cell-derived S100 alarmins induced by Candida albicans via pattern recognition receptor interactions are sufficient but not necessary for the acute neutrophil response during experimental vaginal candidiasis Infection and Immunity 82(2): 783-792Gunther, L.S.A.; Martins, H.P.R.; Gimenes, F.íc.; Abreu, A.é L.P.d.; Consolaro, M.E.L.; Svidzinski, T.I.E. 2014: Prevalence of Candida albicans and non-albicans isolates from vaginal secretions: comparative evaluation of colonization, vaginal candidiasis and recurrent vaginal candidiasis in diabetic and non-diabetic women Sao Paulo Medical Journal 132(2): 116-120
Roselletti, E.; Perito, S.; Sabbatini, S.; Monari, C.; Vecchiarelli, A. 2019: Vaginal Epithelial Cells Discriminate Between Yeast and Hyphae of Candida albicans in Women who Are Colonized or have Vaginal Candidiasis Journal of Infectious Diseases 220(10): 1645-1654
Trumbore, D.J.; Sobel, J.D. 1986: Recurrent vulvovaginal candidiasis: vaginal epithelial cell susceptibility to Candida albicans adherence Obstetrics and Gynecology 67(6): 810-812
Trumbore, D.J.; Sobel, J.D. 1986: Recurrent vulvovaginal candidiasis: vaginal epithelial cell susceptibility to Candida albicans adherence Obstetrics and Gynecology (New York 1953) 67(6): 810-812
Piccinni, M.-P.; Vultaggio, A.; Scaletti, C.; Livi, C.; Gomez, M.J.; Giudizi, M.G.; Biagiotti, R.; Cassone, A.; Romagnani, S.; Maggi, E. 2002: Type 1 T helper cells specific for Candida albicans antigens in peripheral blood and vaginal mucosa of women with recurrent vaginal candidiasis Journal of Infectious Diseases 186(1): 87-93
Jafari, M.; Salari, S.; Pakshir, K.; Zomorodian, K. 2017: Exoenzyme activity and possibility identification of Candida dubliniensis among Candida albicans species isolated from vaginal candidiasis Microbial Pathogenesis 110: 73-77
De Bernardis, F.; Liu, H.; O'Mahony, R.; La Valle, R.; Bartollino, S.; Sandini, S.; Grant, S.; Brewis, N.; Tomlinson, I.; Basset, R.C.; Holton, J.; Roitt, I.M.; Cassone, A. 2007: Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis Journal of Infectious Diseases 195(1): 149-157
Schaller, M.; Korting, H.C.; Borelli, C.; Hamm, G.; Hube, B. 2005: Candida albicans-secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis Infection and Immunity 73(5): 2758-2765
Regúlez, P.; García Fernández, J.F.; Moragues, M.D.; Schneider, J.; Quindós, G.; Pontón, J. 1994: Detection of anti-Candida albicans IgE antibodies in vaginal washes from patients with acute vulvovaginal candidiasis Gynecologic and Obstetric Investigation 37(2): 110-114
Kalkanci, A.; Taysi, B., N.; Mansuroglu, H.; Senel, K.; Kustimur, S. 1999: The species distribution in patients with vaginal candidiasis and value of serum anti-Candida albicans immunoglobulin G positivity Mikrobiyoloji Bulteni 33(4): 327-332
Barousse, M.M.; Yano, J.; Espinosa, T.; Dunlap, K.; Fidel, P.L., J. 2006: Innate immune activities following the interaction of Candida with vaginal epithelial cells associated with the aggressive neutrophil response during symptomatic vulvovaginal candidiasis Abstracts of the General Meeting of the American Society for 106): 245
Raska, M.; Belakova, J.; Horynova, M.; Krupka, M.; Novotny, J.; Sebestova, M.; Weigl, E. 2008: Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis Medical Mycology 46(5): 411-420
Nomanbhoy, F.; Steele, C.; Yano, J.; Fidel, P.L. 2002: Vaginal and oral epithelial cell anti-Candida activity Infection and Immunity 70(12): 7081-7088
Yano, J.; Lilly, E.A.; Steele, C.; Fortenberry, D.; Fidel, P.L. 2005: Oral and vaginal epithelial cell anti-Candida activity is acid labile and does not require live epithelial cells Oral Microbiology and Immunology 20(4): 199-205
She, X-Dong.; Wang, X-Jun.; Fu, M-Hua.; Shen, Y-Nian.; Liu, W-Da. 2008: Genotype comparisons of strains of Candida albicans from patients with cutaneous candidiasis and vaginal candidiasis Chinese Medical Journal 121(15): 1450-1455
Wagner, R. Doug; Johnson, S J.; Tucker, D R. 2012: Protection of Vaginal Epithelial Cells with Probiotic Lactobacilli and the Effect of Estrogen against Infection by Candida albicans Open Journal of Medical Microbiology 02(03): 54-64
Santos, P.íc.O.; Melo, J.O.; Ponzzes, C.M.P.B.S.; Alves, J.é A.ôn.B.; de Melo, D.ân.L.F.M.; Botelho, N.d.S.; Yamada-Ogatta, S.F.; Mann, R.S.; Trindade, R.d.C.ás. 2012: Multilocus enzyme electrophoresis analysis and exoenzymatic activity of Candida albicans strains isolated from women with vaginal candidiasis Mycoses 55(1): 64-72
Cauwenbergh, G. 1990: New directions in diagnosis and therapy of vulvovaginal candidiasis vaginal candidiasis evolving trends in the incidence and treatment of non candida albicans infections Current Problems in Obstetrics, Gynecology and Fertility 13(6): 241-245
Cárdenas-Freytag, L.; Steele, C.; Wormley, F.L.; Cheng, E.; Clements, J.D.; Fidel, P.L. 2002: Partial protection against experimental vaginal candidiasis after mucosal vaccination with heat-killed Candida albicans and the mucosal adjuvant LT(R192G) Medical Mycology 40(3): 291-299